Blogger's Note: Hartzband and Groopman article previously posted on blog, try searching blog "Forbes"
Medicine Must Allow for Customization: A Lesson for Policy-Makers -- and Regulators - Forbes
"As appealing as it is – as useful as it is – to imagine that there
exists a gold-standard way to practice medicine, and a single-best way
to approach most human ailments, the reality is considerably more
complex and messy, as
Hartzband and Groopman’s (continued)
critique of so-called “best practices” makes clear.
The heart of their argument is this: “For patients and experts alike,
there is a subjective core to every medical decision. The truth is
that, despite many advances,
much of medicine still exists in a gray
zone where there is not one right answer. No one can say with certainty
who will benefit by taking a certain drug and who will not. Nor can we
say with certainty what impact a medical condition will have on
someone’s life or how they might experience a treatment’s side effects.
The path to maintaining or regaining health is not the same for
everyone; our preferences really do matter.”
This resonates (see
here and
here),
although I’ve also heard distinguished health policy proponents argue
convincingly that even if experts can’t agree what is definitely
“right,” there can definitely be agreement about a number of ways of
practicing medicine that are clearly “wrong,” yet very common – so that
while it may be harmful, and disingenuous, to insist upon a single
algorithm or best approach, it could be helpful to at least provide
clear guidance so that physicians would know to avoid certain
therapeutic approaches.
Not only does Hartzband and Groopman’s argument have implications for
the current healthcare debate, it also would seem to have significant
implications for the way we view medical product regulation..........
